Gazprom OAO OGZPY Company Overview  Stock Message Board

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
Gazprom OAO OGZPY Company Overview 

Stock Message Board http://investorshangout.com/search?q=OGZPY&am...mp;yt1=Go!

Gazprom OAO OGZPY Current Price and Quotes
7.805
Previous Close
7.82
Open
7.82

Daily Range
7.85 - 7.79
52wk Range
11.20 - 6.44

Volume
276,900
Dividend
0.2864

Average Vol (3m)
763,715
Yield
3.6694

Gazprom OAO OGZPY
Company Information
16 Nametkina St.
117997
V-420, GSP-7
Moscow
Russian Federation

Website: http://www.gazprom.com
Phone: +7 495 719-30-01
Email: gazprom@gazprom.ru

Gazprom OAO OGZPY
Gazprom extracts, transports, stores and sells natural gas. The company is the successor to the State-owned company. Gazprom owns and operates Russia's Unified Gas Supply System. The company has a monopoly in supplying gas in the Russian Federation, and exports natural gas to Western Europe.

Gazprom OAO OGZPY
Financial Reportings and Disclosures
Reporting Status International Reporting: RTS-Russian Trading System Stock Exchange
Fiscal Year End 12/31
OTC Marketplace OTC Pink Current
Profile Data
SIC - Industry Classification 8880 - American Depositary Receipts
Incorporated In: Russian Federation
Year of Inc. 1992
Employees 402000 a/o Dec 31, 0005
Company Officers/Contacts
Oxana Yu Bestoujeva General Director
Petr Rodionov Deputy Chairman
Maxim Oirakh Executive Director
Andrey Orlov Deputy Head of Capital Markets
Elena A. Vasilieva Chief Accounting Officer
Andrey Baranov IR
Company Directors
Dmitri A. Medvedev Chairman
Service Providers
Auditor/Accountant
Not Available
Legal Counsel
Not Available
Investor Relations Firm
Not Available

Gazprom OAO OGZPY
OGZPY Security Details Other Company Securities
Share Structure
Market Value1 $92,385,872,775 a/o Aug 30, 2013
Shares Outstanding 23,673,510,000 a/o Dec 31, 2010
Float Not Available
Authorized Shares Not Available
Par Value  No Par Value
Shareholders
Shareholders of Record Not Available
Corporate Actions
Ex. Date Record Date Pay Date
Dividend (0.28642) *  May 13, 2013 Sep 05, 2013
Dividend (0.00) *  May 13, 2013
Dividend (0.45535) *  May 10, 2012 Sep 05, 2012
Security Notes
Capital Change=shs increased by 2.5 for 1 split. Ratio changed=1 ADR to 4 Ord shs from 1 ADR to 10 Ord shs Ex-date=04/19/2006. Rec date=04/14/2006. Pay date=04/18/2006.
Capital Change=Stk. Div.=100%. Ex-date=04/26/2011. Rec date=04/20/2011. Pay date=04/21/2011.
Non US Stock Exchange Listing
GAZP - RTS-Russian Trading System Stock Exchange - Qualified
Short Selling Data
Short Interest 24,451,023 (-3.07%)
Aug 15, 2013
Significant Failures to Deliver  No
Transfer Agent(s)
BNY Mellon

Gazprom OAO OGZPY Recent News

Gazprom OAO OGZPY Financials
Data is unavailable at this time. Please check this page later.

OGZPY Gazprom OAO Research DD Guide

OGZPY Gazprom OAO Stock Message Board http://investorshangout.com/search?q=OGZPY&am...mp;yt0=Go!
OGZPY Gazprom OAO Stock Quote http://www.otcmarkets.com/stock/OGZPY/quote
OGZPY Gazprom OAO Stock Chart http://www.otcmarkets.com/stock/OGZPY/chart
OGZPY Gazprom OAO Company Info http://www.otcmarkets.com/stock/OGZPY/company-info
OGZPY Gazprom OAO Recent News http://www.otcmarkets.com/stock/OGZPY/news
OGZPY Gazprom OAO Financials http://www.otcmarkets.com/stock/OGZPY/financials
OGZPY Gazprom OAO Filings and Disclosure http://www.otcmarkets.com/stock/OGZPY/filings
OGZPY Gazprom OAO Short Sales http://www.otcmarkets.com/stock/OGZPY/short-sales
OGZPY Gazprom OAO Insider Disclosure http://www.otcmarkets.com/stock/OGZPY/insider-transactions
OGZPY Gazprom OAO Research Reports http://www.otcmarkets.com/stock/OGZPY/research
OGZPY Gazprom OAO Summary http://finance.yahoo.com/q?s=OGZPY
OGZPY Gazprom OAO Historical Prices http://finance.yahoo.com/q/hp?s=OGZPY+Historical+Prices
OGZPY Gazprom OAO Interactive Chart http://finance.yahoo.com/echarts?s=OGZPY
OGZPY Gazprom OAO Basic Chart http://finance.yahoo.com/q/bc?s=OGZPY+Basic+Chart
OGZPY Gazprom OAO Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=OGZPY+Basic+Tech.+Analysis
OGZPY Gazprom OAO Headlines http://finance.yahoo.com/q/h?s=OGZPY+Headlines
OGZPY Gazprom OAO Press Releases http://finance.yahoo.com/q/p?s=OGZPY+Press+Releases
OGZPY Gazprom OAO Company Profile http://finance.yahoo.com/q/pr?s=OGZPY+Profile
OGZPY Gazprom OAO Key Statistics http://finance.yahoo.com/q/ks?s=OGZPY+Key+Statistics
OGZPY Gazprom OAO Industry http://finance.yahoo.com/q/in?s=OGZPY+Industry
OGZPY Gazprom OAO Major Holders http://finance.yahoo.com/q/mh?s=OGZPY+Major+Holders
OGZPY Gazprom OAO Insider Transactions http://finance.yahoo.com/q/it?s=OGZPY+Insider+Transactions
OGZPY Gazprom OAO Insider Roster http://finance.yahoo.com/q/ir?s=OGZPY+Insider+Roster
OGZPY Gazprom OAO Income Statement http://finance.yahoo.com/q/is?s=OGZPY
OGZPY Gazprom OAO Balance Sheet http://finance.yahoo.com/q/bs?s=OGZPY
OGZPY Gazprom OAO Cash Flow http://finance.yahoo.com/q/cf?s=OGZPY+Cash+Flow&annual
OGZPY Gazprom OAO Nasdaq http://www.nasdaq.com/symbol/OGZPY
OGZPY Gazprom OAO Market Watch http://www.marketwatch.com/investing/stock/OGZPY
OGZPY Gazprom OAO Bloomberg http://www.bloomberg.com/quote/OGZPY:US
OGZPY Gazprom OAO Morningstar http://quotes.morningstar.com/stock/s?t=OGZPY
OGZPY Gazprom OAO Bussinessweek http://investing.businessweek.com/research/st...cker=OGZPY
OGZPY Gazprom OAO Barchart http://www.barchart.com/quotes/stocks/OGZPY
OGZPY Gazprom OAO OTC Short Report http://otcshortreport.com/index.php?index=OGZPY
OGZPY Gazprom OAO Investopedia http://www.investopedia.com/markets/stocks/OGZPY/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 29

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 23

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 17

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 16

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 22

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 23

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading

Top 5 Most Recently Viewed Articles

Context Therapeutics Gains Confidence with Strategic Developments

Updated Category News Views 60

Piper Sandler's Renewed Confidence in Context Therapeutics Piper Sandler has reiterated an Overweight rating for Context Therapeutics (NASDAQ: CNTX), maintaining a price target of $4.50 for the stock. This endorsement underscores their belief in the company’s potential within the biopharmaceutical sector. Positive Data from Competitors Enhances Expectations This renewed...

Continue Reading
Actinium's ATNM-400: A Promising Frontier in Prostate Cancer Therapy

Updated Category News Views 167

Introduction to ATNM-400's Innovative Approach Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) has announced compelling preclinical data showcasing its innovative treatment, ATNM-400. This first-in-class antibody radioconjugate targets a unique, non-PSMA antigen, revolutionizing prostate cancer therapy. ATNM-400 offers noteworthy therapeutic activity independent of...

Continue Reading
Opportunity Knocks: Ligon's Major Auction Up for Bids

Updated Category News Views 17

Equipment Auction Offers Unique Buying Opportunity Catch this: Ligon Co.'s auction is like finding a needle in a haystack in a world of overpriced equipment. We're talking about a smorgasbord of heavy machinery up for online grabs, and it’s happening until June 17. Auction Highlights: Your Next Business Asset? From telehandlers to trailers, this ain't your everyday yard...

Continue Reading
Selector Enhances Service Delivery with AWS Marketplace Launch

Updated Category News Views 147

Selector Launches on AWS Marketplace for Better Accessibility Selector, a pioneer in AI-driven observability and network intelligence, is transforming how organizations manage their network operations. The company has launched its flagship platform on the Amazon Web Services (AWS) Marketplace, which makes it easier for customers to procure and deploy its powerful AI tools...

Continue Reading
Exploring the Surge in Decentralized Energy Storage Growth

Updated Category News Views 229

Decentralized Energy Storage Market Overview The Decentralized Energy Storage market is gaining remarkable traction, with significant insights indicating a shift towards sustainable energy solutions. Valued at approximately USD 10.88 billion, the market is anticipated to expand to a staggering USD 35.62 billion, exhibiting a compound annual growth rate (CAGR) of 15.98%...

Continue Reading